LFB, a company committed to saving patients
LFB is a French biopharmaceutical group that develops, manufactures and markets plasma-derived medicinal products and recombinant proteins for the treatment of patients with serious and often rare diseases.
Created in France in 1994, LFB today is a leading European company providing plasma-derived medicinal products to healthcare professionals. Its mission is to offer patients new treatment options for unmet needs in three major therapeutic areas: immunology, haemostasis, and intensive care.
LFB is a public company operating in a competitive sector. LFB currently markets about fifteen medicinal products in more than 30 countries.
